Takeda Becomes the Latest to Notch an Alzheimer's Failure Under Its Belt Post author:Sam Post published:January 24, 2018 Post category:BioPharma Another experimental Alzheimer’s disease treatment has failed in a late-stage study. Source: BioSpace You Might Also Like <b>Epicore BioNetworks Inc.</b> Reports Quarter Three Results For Fiscal Year 2017 For The Quarter Ended 31 March 2017, In U.S. Dollars May 17, 2017 3 Biotech Stocks Able to Weather an Unstable Administration February 9, 2017 Foghorn Therapeutics Launches with $50 Million March 13, 2018
<b>Epicore BioNetworks Inc.</b> Reports Quarter Three Results For Fiscal Year 2017 For The Quarter Ended 31 March 2017, In U.S. Dollars May 17, 2017
